Ursprung des Netzwerks ersten Grades von Elizabeth Jones
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Acambis Plc
Acambis Plc BiotechnologyHealth Technology Acambis Plc develops biopharmaceutical products and vaccines. It offers ACAM2000, a smallpox vaccine for emergency-use stockpiling; and ChimeriVax-JE, a single-dose Japanese encephalitis vaccine for endemic markets and travelers. Its products in pipeline include ChimeriVax-JE, ChimeriVax-West Nile, and ChimeriVax-Dengue. The company was founded in 1992 and is headquartered in Cambridge, UK.
7
| Subsidiary | Biotechnology | 7 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Elizabeth Jones
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
VERNALIS | Pharmaceuticals: Major | Founder | |
HBM Partners AG
HBM Partners AG Investment ManagersFinance HBM Partners AG (HBM-P) was established in 2001 as an independent provider of investment advisory services with headquarters in Zug, Switzerland. HBM-P's field of expertise comprises global human medicine, biotechnology, medical technology and related sectors. The firm primarily advises HBM BioVentures AG and HBM BioCapital via their Cayman Islands-based, wholly-owned subsidiary, HBM Partners (Cayman) Ltd., which acts as the investment manager for the HBM funds. They rely on the services of an external consultant to analyze investment opportunities in the US. | Investment Managers | Private Equity Investor | |
Neusentis, Inc.
Neusentis, Inc. Pharmaceuticals: MajorHealth Technology Neusentis is a biopharmaceutical company, which is focused on the discovery, development and commercialization of novel orally-administered small molecule drugs that modulate ion channel targets. The company has developed an integrated technology platform that allows for the efficient discovery of drug leads. The firm is conducting research and development activities in a number of disease areas, including epilepsy, pain and inflammation. Icagen has two clinical stage programs in epilepsy and pain. The company was formerly known as Icagen, Inc. It was founded by Andre L. Lamotte and P. Kay Wagoner on November 23, 1992 and is headquartered in Durham, NC. | Pharmaceuticals: Major | Founder | |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Masters Business Admin | |
WILLIAM HILL | Movies/Entertainment | Investor Relations Contact | |
University of Southern California
University of Southern California Other Consumer ServicesConsumer Services University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA. | College/University | Doctorate Degree | |
Associated British Ports Holdings Plc /Cardiff Bay Estates/ | Real Estate Development | Corporate Officer/Principal | |
Creagen, Inc.
Creagen, Inc. Pharmaceuticals: OtherHealth Technology Part of Perrigo Co. Plc, Creagen, Inc. is a biopharmaceutical development company. The company is based in Cambridge, MA. The company was founded by André L. Lamotte, Roberto Crea. Creagen was acquired by Neurex Corp. on July 26, 1994 for $8.05 million. | Pharmaceuticals: Other | Founder | |
Axovan AG
Axovan AG Miscellaneous Commercial ServicesCommercial Services Axovan AG conducts biopharmaceutical research and develops pharmaceuticals. Active in pharmaceutical research and development, it focuses on the family of drug targets called G protein-coupled receptors (GPCRs), which are involved in a number of pathologies. It has developed a validated GPCR-based chemical library through its proprietary chem-informatics platform AXADDIS. Its lead product, clasozentan, is an intravenous endothelin receptor antagonist optimized for treating cerebral diseases. It is partnering non-core indication projects (pain, metabolic diseases, inflammation) at earlier stages. The company was founded in 2000 and is headquartered in Allschwil, Switzerland. | Miscellaneous Commercial Services | Founder | |
BioVex Ltd.
BioVex Ltd. Miscellaneous Commercial ServicesCommercial Services BioVex Ltd. operates as a biotechnology firm. It focuses on the development and commercialization of biological treatments for cancer and the prevention of infectious disease. The company was founded on December 15, 1997 and is headquartered in Cambridge, the United Kingdom. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Massachusetts Institute of Technology | College/University | Doctorate Degree | |
University of London | College/University | Doctorate Degree | |
University of Birmingham | College/University | Doctorate Degree | |
MSD Vaccines Ltd.
MSD Vaccines Ltd. Pharmaceuticals: OtherHealth Technology MSD Vaccines Ltd. manufactures and supplies vaccines. Its main way of achieving this goal is to develop and make available innovative vaccines against a wide spectrum of diseases. It also dedicated to increasing the understanding of the value of vaccines and vaccination by providing relevant and accurate information on their quality, safety and efficacy. The company was founded in 1975 and is headquartered in Maidenhead, the United Kingdom. | Pharmaceuticals: Other | Director/Board Member | |
The State University of New York | College/University | Undergraduate Degree | |
Pasteur Mérieux Connaught | Corporate Officer/Principal | ||
Diatide, Inc.
Diatide, Inc. Pharmaceuticals: GenericHealth Technology Diatide, Inc. is a company based in Londonderry, NH. Diatide, Inc. was founded by André L. Lamotte. | Pharmaceuticals: Generic | Founder | |
Pasteur Merieux, Inc. | Corporate Officer/Principal | ||
URRMA Biopharma, Inc. | Founder | ||
Urma AG | Director/Board Member | ||
EVOLVA HOLDING SA | Food: Specialty/Candy | Founder | |
Medical Specialty Products International AG | Director/Board Member | ||
Valera LLC
Valera LLC BiotechnologyHealth Technology Part of Moderna, Inc., Valera LLC is a company that develops and markets vaccines. The company is based in Cambridge, MA. | Biotechnology | President | |
SK BIOSCIENCE CO.,LTD. | Biotechnology | Corporate Officer/Principal |
Statistik
International
Vereinigte Staaten | 14 |
Vereinigtes Königreich | 10 |
Schweiz | 8 |
Kanada | 3 |
Australien | 2 |
Sektoral
Health Technology | 13 |
Finance | 7 |
Consumer Services | 7 |
Commercial Services | 3 |
Technology Services | 2 |
Operativ
Founder | 13 |
Corporate Officer/Principal | 12 |
Director/Board Member | 8 |
Doctorate Degree | 4 |
Sales & Marketing | 2 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Elizabeth Jones
- Unternehmensverbindungen